About the journal
Cancer Science is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,350 EUR. Declared review time at DOAJ: 17 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 1347-9032 · 1349-7006
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,350 EUR
- Articles in DOAJ
- 0
- Declared review time
- 17 weeks
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/13497006
Index listings
- DOAJ · 2014-09-26
- MEDLINE · 2003-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 2,350 EUR
- Declared review time (DOAJ)
- 17 weeks
- Actual review time (measured)
- 113 days received→accepted — computed from PubMed (n=96)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
17weeks
Works in OpenAlex
8052
Last recorded publication year
2026
h-index
186
i10-index
5644
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2014-09-26
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 84%
- ORCID iDs in current deposits
- 83%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Source type
- journal
- NLM unique ID (PubMed)
- 101168776
- Society affiliations
- Japanese Cancer Association
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- RNA modifications and cancer
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer-related gene regulation
- Cancer-related gene regulation
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Immune cells in cancer
- Immune cells in cancer
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- RNA Research and Splicing
- RNA Research and Splicing
- CAR-T cell therapy research
- CAR-T cell therapy research
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- DNA Repair Mechanisms
- Cancer Research and Treatments
- DNA Repair Mechanisms
- Cancer Research and Treatments
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
Keywords (DOAJ)
- oncology
- cancer research
- palliative care
- radiotherapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ